Rice Hall James & Associates LLC Purchases 33,064 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Rice Hall James & Associates LLC lifted its position in Utah Medical Products, Inc. (NASDAQ:UTMD) by 73.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 78,053 shares of the medical instruments supplier’s stock after purchasing an additional 33,064 shares during the quarter. Rice Hall James & Associates LLC owned 2.10% of Utah Medical Products worth $7,470,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. BNP Paribas Arbitrage SA raised its stake in shares of Utah Medical Products by 428.7% during the 1st quarter. BNP Paribas Arbitrage SA now owns 719 shares of the medical instruments supplier’s stock valued at $63,000 after buying an additional 583 shares during the last quarter. Aperio Group LLC acquired a new position in Utah Medical Products during the 2nd quarter valued at about $76,000. Metropolitan Life Insurance Co. NY boosted its stake in Utah Medical Products by 605.0% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 1,537 shares of the medical instruments supplier’s stock valued at $128,000 after purchasing an additional 1,319 shares during the period. Bank of America Corp DE boosted its stake in Utah Medical Products by 132.2% during the 4th quarter. Bank of America Corp DE now owns 2,190 shares of the medical instruments supplier’s stock valued at $182,000 after purchasing an additional 1,247 shares during the period. Finally, Mercer Global Advisors Inc. ADV acquired a new position in Utah Medical Products during the 1st quarter valued at about $224,000. 74.67% of the stock is currently owned by institutional investors and hedge funds.

Separately, BidaskClub raised shares of Utah Medical Products from a “hold” rating to a “buy” rating in a report on Saturday, August 10th.

Shares of NASDAQ:UTMD traded down $0.07 on Thursday, hitting $95.93. The company’s stock had a trading volume of 150 shares, compared to its average volume of 14,454. The firm’s 50-day moving average price is $89.60. Utah Medical Products, Inc. has a 1 year low of $73.98 and a 1 year high of $102.70. The stock has a market cap of $361.02 million, a P/E ratio of 26.45 and a beta of 0.83.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 3rd. Shareholders of record on Friday, September 13th will be issued a $0.275 dividend. The ex-dividend date of this dividend is Thursday, September 12th. This represents a $1.10 annualized dividend and a dividend yield of 1.15%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.

Featured Story: How to Calculate Compound Annual Growth Rate (CAGR)

Institutional Ownership by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.